tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
Holding ABOS?
Track your performance easily

Acumen Pharmaceuticals (ABOS) Hedge Fund Trading Activity

408 Followers
Trend: No Trend Detected

Hedge Fund Holdings in ABOS

Based on the 13F filings of 487 Hedge Funds submitted to the SEC.
See how hedge fund holdings have changed over the past year. The columns represent the number of shares owned by hedge funds.

Hedge Fund Confidence Signal

Neutral
Stock Sentiment
Sold
Bought
Based on activity of 1 Hedge Funds in the recent quarter
A unique signal which shows hedge fund sentiment according to recent transactions.

Hedge Fund Activity​

Activity
Any
Any
Star Ranking
Any
Any
Hedge Fund Manager
Star Ranking
Firm
Activity
Holding Change
Value Reported
% of Portfolio
Follow
RA Capital Management
Not Changed
0.00%
$37031516
0.43%

FAQ

Which hedge funds hold Acumen Pharmaceuticals?
The hedge funds that hold the most shares in Acumen Pharmaceuticals are Peter Kolchinsky and undefined.
    Are hedge funds buying or selling ABOS?
    Currently, no data Available
    Where can I see a list of the best rated hedge funds?
    You can see a list of the best hedge funds here.
      Who is the best-performing hedge fund manager?
      The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
        Does Warren Buffet hold shares in Acumen Pharmaceuticals stock?
        Warren Buffet currently does not own shares in Acumen Pharmaceuticals.
        What is a 13F filing, and how does it help investors?
        A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis